This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2017 Aug 1;35(22):2590.

doi: 10.1200/JCO.2017.74.5729.

Errata

No authors listed

PMID: 28750184
PMCID: PMC6161974
DOI: 10.1200/JCO.2017.74.5729

Published Erratum

Errata

No authors listed. J Clin Oncol. 2017.

. 2017 Aug 1;35(22):2590.

doi: 10.1200/JCO.2017.74.5729.

PMID: 28750184
PMCID: PMC6161974
DOI: 10.1200/JCO.2017.74.5729

No abstract available

PubMed Disclaimer

Erratum for

Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.
Cainap C, Qin S, Huang WT, Chung IJ, Pan H, Cheng Y, Kudo M, Kang YK, Chen PJ, Toh HC, Gorbunova V, Eskens FA, Qian J, McKee MD, Ricker JL, Carlson DM, El-Nowiem S. Cainap C, et al. J Clin Oncol. 2015 Jan 10;33(2):172-9. doi: 10.1200/JCO.2013.54.3298. Epub 2014 Dec 8. J Clin Oncol. 2015. PMID: 25488963 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations